Drug resistance and its significance for treatment decisions in non-small-cell lung cancer

Por Tsvetkova, E., Goss, G.D.
Publicado em 2012

Deoxyhaemoglobin concentrations in the detection of central cyanosis.

Por Goss, G A, Hayes, J A, Burdon, J G
Publicado em 1988

The hexokinase activity of animal tumours

Por Boyland, E., Goss, G. C. L., Williams-Ashman, H. G.
Publicado em 1951

A personalized approach to treatment: use of egfr tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer in Canada

Por Hirsh, V., Melosky, B., Goss, G., Morris, D., Morzycki, W.
Publicado em 2012

Corrigendum: A personalized approach to treatment: use of egfr tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer in Canada

Por Hirsh, V., Melosky, B., Goss, G., Morris, D., Morzycki, W.
Publicado em 2012

Chemotherapy in recurrent advanced non-small-cell lung cancer after adjuvant chemotherapy

Por Valdes, M., Nicholas, G., Goss, G.D., Wheatley-Price, P.
Publicado no Curr Oncol (2016)

A Comparison of Dark Adaptation (Biophotometer) Tests on French and English School Children in a Quebec Community

Por Goss, G. C. L., Farmer, Florence A., McFarlane, W. D.
Publicado em 1941

Adult respiratory distress syndrome in Leptospira canicola infection.

Por Zaltzman, M, Kallenbach, J M, Goss, G D, Lewis, M, Zwi, S, Gear, J H
Publicado em 1981

The 4th Annual Ontario Thoracic Cancer Conference at Niagara-on-the-Lake

Por Ung, Y.C., Yu, E., Malthaner, R., Burkes, R., Ellis, P., Goss, G., Solow, H., Irvine, S., Laffan, S.
Publicado em 2009

A retrospective review of cancer treatments and outcomes among Inuit referred from Nunavut, Canada

Por Asmis, T.R., Febbraro, M., Alvarez, G.G., Spaans, J.N., Ruta, M., Lalany, A., Osborne, G., Goss, G.D.
Publicado no Curr Oncol (2015)

The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national conse...

Por Ellis, P.M., Morzycki, W., Melosky, B., Butts, C., Hirsh, V., Krasnoshtein, F., Murray, N., Shepherd, F.A., Soulieres, D., Tsao, M.S., Goss, G.
Publicado em 2009

A phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer (NSCLC). A study of the PMH Phase II Consortium

Por Leighl, NB, Laurie, SA, Chen, XE, Ellis, P, Shepherd, FA, Knox, JJ, Goss, G, Burkes, RL, Pond, GR, Dick, C, Yen, Y, Zwiebel, JA, Moore, MJ
Publicado em 2009

A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCO...

Por Banerjee, S., Rustin, G., Paul, J., Williams, C., Pledge, S., Gabra, H., Skailes, G., Lamont, A., Hindley, A., Goss, G., Gilby, E., Hogg, M., Harper, P., Kipps, E., Lewsley, L-A, Hall, M., Vasey, P., Kaye, S. B.
Publicado no Ann Oncol (2012)

A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas

Por Duran, I, Kortmansky, J, Singh, D, Hirte, H, Kocha, W, Goss, G, Le, L, Oza, A, Nicklee, T, Ho, J, Birle, D, Pond, G R, Arboine, D, Dancey, J, Aviel-Ronen, S, Tsao, M-S, Hedley, D, Siu, L L
Publicado em 2006

A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors

Por Jonker, D. J., Rosen, L. S., Sawyer, M. B., de Braud, F., Wilding, G., Sweeney, C. J., Jayson, G. C., McArthur, G. A., Rustin, G., Goss, G., Kantor, J., Velasquez, L., Syed, S., Mokliatchouk, O., Feltquate, D. M., Kollia, G., Nuyten, D. S. A., Galbraith, S.
Publicado em 2011